Healthy brain aging and delayed dementia in Texas rural elderly

T Basu, U Sehar, K Malhotra, J Culberson… - Ageing Research …, 2023 - Elsevier
Healthy aging is the process of preserving and enhancing one's independence, physical
and mental well-being, and overall quality of life. It involves the mental, emotional, and …

Alzheimer disease

EM McDade - CONTINUUM: Lifelong Learning in Neurology, 2022 - journals.lww.com
Alzheimer Disease : CONTINUUM: Lifelong Learning in Neurology Account Register
Activate Subscription Help Subscribe American Academy of Neurology Login Journal logo …

Health psychology: Theory, research and practice

DF Marks, M Murray, A Locke, RA Annunziato… - 2024 - torrossa.com
Welcome to Health Psychology: Theory, Research and Practice (Seventh Edition). This
textbook provides an in-depth introduction to the growing field of health psychology. It is …

Clinicoradiologic and neuropathologic evaluation of corticobasal syndrome

D Shir, NTT Pham, H Botha, S Koga, N Kouri, F Ali… - Neurology, 2023 - AAN Enterprises
Background and Objectives Corticobasal syndrome (CBS) is a clinical phenotype
characterized by asymmetric parkinsonism, rigidity, myoclonus, and apraxia. Originally …

Association of kidney function with dementia and structural brain differences: a large population-based cohort study

S Wang, J Wang, J Guo, A Dove, H Xu… - The Journals of …, 2024 - academic.oup.com
Background The association between kidney function and dementia risk and the
mechanisms underlying this relationship remain unclear. Methods Within the UK Biobank …

Genetic risk scores enhance the diagnostic value of plasma biomarkers of brain amyloidosis

VK Ramanan, RK Gebre, J Graff-Radford, E Hofrenning… - Brain, 2023 - academic.oup.com
Blood-based biomarkers offer strong potential to revolutionize diagnosis, trial enrolment and
treatment monitoring in Alzheimer's disease (AD). However, further advances are needed …

[HTML][HTML] Alcohol Use Disorder and Dementia: A Review

NM Zahr - Alcohol Research: Current Reviews, 2024 - ncbi.nlm.nih.gov
PURPOSE By 2040, 21.6% of Americans will be over age 65, and the population of those
older than age 85 is estimated to reach 14.4 million. Although not causative, older age is a …

Clinically feasible automated MRI volumetry of the brain as a prognostic marker in subjective and mild cognitive impairment

R Amland, G Selbæk, A Brækhus, TH Edwin… - Frontiers in …, 2024 - frontiersin.org
Background/aims The number of patients suffering from cognitive decline and dementia
increases, and new possible treatments are being developed. Thus, the need for time …

Exploring the Regulatory Landscape of Dementia: Insights from Non-Coding RNAs

J Kim, WR Kim, EG Park, DH Lee, YJ Lee… - International Journal of …, 2024 - mdpi.com
Dementia, a multifaceted neurological syndrome characterized by cognitive decline, poses
significant challenges to daily functioning. The main causes of dementia, including …

The use of an anterior-posterior atrophy index to distinguish Alzheimer's disease from frontotemporal disorders: an automated volumetric MRI Study

LR Gerlach, V Prabhakaran, PG Antuono… - Acta …, 2024 - journals.sagepub.com
Background Alzheimer's disease (AD) and frontotemporal dementia (FTD) require different
treatments. Since clinical presentation can be nuanced, imaging biomarkers aid in …